Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
Shariq Shamim, Interventional Cardiologist at Bon Secours Harbour View Medical Center, shared JAMA Cardiology‘s post on X:
“Are we going to start DOAC post TAVI not DAPT?”
JAMA Cardiology shared a post on X about a recent article by Christopher S. Dodgson et al. published in JAMA, adding:
“Presented at ESC Congress from JAMA:
After Transcatheter Aortic Valve Implant, factor Xa inhibitor non–vitamin K antagonist oral anticoagulant monotherapy reduced hypoattenuated leaflet thickening vs acetylsalicylic acid monotherapy.”
Title: Anticoagulation Monotherapy vs Antiplatelet Monotherapy After Transcatheter Aortic Valve Implant: The ACASA-TAVI Randomized Clinical Trial
Authors: Christopher S. Dodgson, Jon Herstad, Sophie F. Kløve, Malin Flygel, Mehdi Akhavi, Sverre Høie, Jan Otto Beitnes, Christian H. Eek, Kaspar Broch, Céline Cunen, Lars Gullestad, Lars Aaberge, Ketil Lunde, Bjørn Bendz, Øyvind H. Lie
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment
-
Oct 19, 2026, 16:04Hussnain Javaid: New EHA Guidelines for HbSC Disease Management
-
Oct 19, 2026, 15:50Deep Madkaiker: A New Academic Opportunity in Transfusion Medicine at ACTREC
-
Oct 19, 2026, 15:19Why Hematologists Should Care About Diminished Ovarian Reserve in SCD – ASH Education